baber/WOPTO huggingface dataset:
Patent NZ-563073-A (NZ)
Title: Interactive large scale touch surface system
Inventor: HILL DOUGLAS
IPC: G06F3/01
Filed: 2006-05-02
Abstract: A method of facilitating user interaction with an image displayed on a touch surface of a large scale touch system is disclosed. Images of the touch surface are captured with sets of camera devices positioned in series along the length of the touch surface. Each set of camera devices comprises at least two laterally spaced camera devices having overlapping fields of view oriented to look generally across the touch surface. The captured images are processed to detect user interaction with the touch surface. A scaled version of at least a portion of the displayed image is displayed on the touch surface at a user accessible location in response to an associated input gesture made at an arbitrary location on the touch surface. The scaled version is displayed adjacent the location of the input gesture. Coordinates of the displayed scaled version to the corresponding coordinate portion of the displayed image are mapped so that user interactions with the displayed scaled version are translated to interactions with the displayed image. A writing input region can be further displayed on the touch surface adjacent a user accessible location in response to an associated input gesture made at an arbitrary location on the touch surface. The writing input into the writing input region via pointer interaction with the touch surface is detected and the detected writing input is displayed as text in a text display region on the touch surface at a location spaced from the writing input region. The position of at least one of the writing input region and the text display region on the touch surface is changed in response to user interaction with the touch surface. At least one portion of the displayed image can be reproduced on the touch surface at a user accessible location in response to an associated input gesture made at an arbitrary location on the touch surface and coordinates of the reproduced portion to the corresponding coordinate portion of the displayed image are mapped so that user interactions with the reproduced portion are translated to interactions with the corresponding portion of the displayed image.
Patent NZ-566171-A (NZ)
Title: Method and apparatus for selection of virtual antennas
Inventor: KADOUS TAMER
IPC: H04B7/06
Filed: 2006-08-22
Abstract: Disclosed is a method for receiving and transmitting from virtual antennas rather than physical ones. The method includes selecting a virtual antenna from a plurality of virtual antennas, and then providing an indication of the virtual antenna for use for data transmission. The virtual antennas are formed with a plurality of physical antennas.
Patent NZ-568689-A (NZ)
Title: Supercritical carbon dioxide extraction from Aciphylla plant material
Inventor: ELLESMERE-SLY MICHAEL PINCKNEY
IPC: A61K8/97
Filed: 2008-05-29
Abstract: The technique of near critical extraction, in particular extraction of resins using supercritical carbon dioxide, is applied to plant material of the genus Aciphylla, about 40 species of mountain spear grass such as A.aurea (Golden Spaniard), A. squarrosa (Common Spaniard), and A.colensoi. Maori name Taramea or Karamea. The chopped up plant material is contacted with near critical fluid to produce a near critical fluid phase in which the extract is dissolved, and the near critical fluid phase with dissolved extract is separated from the plant material and subject to a reduced pressure to recover the extract or extracts.
Patent NZ-576950-A (NZ)
Title: Compounds useful as protein kinase inhibitors, particulary PLK1 protein kinases
Inventor: CHARRIER JEAN-DAMIEN
IPC: C07D519/00
Filed: 2007-11-15
Abstract: Disclosed is a compound of formula (I), wherein the substituents are as defined in the specification, and processes for their preparation. The compounds are protein kinase inhibitors useful in the treatment of proliferative disorders, neurodegenerative disorders, autoimmune disorders, inflammatory disorders, or immunologically mediated disorders.
Patent NZ-577865-A (NZ)
Title: Entrapped stem cells and uses thereof
Inventor: CONN BRYAN
IPC: A61K35/13
Filed: 2004-08-09
Abstract: Provided is a composition of matter comprising a sample of human stem cells entrapped in a biocompatible, selectively permeable structure, wherein entrapment of said sample of human stem cells inhibits proliferation of a non-entrapped cell population wherein the human stem cells are selected from the group consisting of non-embryonic human stem cells, pluripotent human stem cells and non-totipotent human stem cell lines. (62) Divided Out of 545542
Patent NZ-581525-A (NZ)
Title: A pharmaceutical composition for treating diabetes and its process for preparation
Inventor: TONG XIAOLIN
IPC: A61K36/233
Filed: 2008-07-28
Abstract: Disclosed is a method for preparing a pharmaceutical composition for treatment of diabetes mellitus, the pharmaceutical composition comprises extracts of the following crude drugs: 5-40 weight parts of Radix Trichosanthis, 10-30 weight parts of Radix Bupleuri, 3-15 weight parts of Fructus Aurantii Immaturus, 1-6 weight parts of Radix et Rhizoma Rhei, 1-12 weight parts of Rhizoma Pinelliae, 3-15 weight parts of Radix Scutellariae, 1-12 weight parts of Rhizoma Coptidis, 3-15 weight parts of Radix Paeoniae Alba and 5-20 weight parts of Fructus Mume, and optionally comprises pharmaceutically acceptable excipient; the pharmaceutical composition is prepared by the methods detailed in the specification. The methods include extracting the drugs with water or ethanol, refluxing, condensing, concerntrating under reduced pressure and optionally adding an excipient. Also disclosed is the pharmaceutical composition obtained by the above methods.
Patent NZ-584583-A (NZ)
Title: A tubular element with vent for a milking teat cup and method for manufacturing
Inventor: CRESPO ERIC
IPC: A01J5/04
Filed: 2008-10-07
Abstract: A tubular element (9) is disclosed with an inner passage for conducting milk. The tubular element (9) comprises a first material portion (9a) which constitutes the main part and an additional material portion (9b) which includes a vent passage (9c) adapted to supply air to the inner space of the tubular element (9). The first material portion (9a) and the additional material portion (9b) are fixedly connected with each other in a contact area (9d) to form an integrated unit. The additional material portion (9b) is positioned so that the vent passage (9c) is located upstream of, in or downstream of a radial inner part of a curved section (9e).
Patent NZ-587445-A (NZ)
Title: A system and method for conducting financial transactions using a mobile device
Inventor: AL-SAHLI MAHMOUD ANASS MAHMOUD
IPC: G06Q20/00
Filed: 2008-05-14
Abstract: 587445 Disclosed is a method for enabling a user of a network enabled mobile device and having a first account at a first financial institution to effect financial transactions by directly accessing the account over a wireless network. The mobile device is associated with a SIM chip having a SIM chip identifier. The method includes providing a system operator in communication with the first financial institution; and registering the mobile device with the system operator and with the first financial institution for acquiring mobile payment capabilities. Registration with the system operator includes associating the SIM chip identifier with the first financial institution and storing the information in a first database accessible to the system operator. Registration with the first financial institution includes associating the SIM chip identifier with the first account and storing the information in a second database accessible to the first financial institution. The method includes establishing a first connection between the mobile device and said system operator. The first connection is initiated by the user using the mobile device. The method also includes inquiring by the system operator if the first connection originates from a registered mobile device by tracing out the mobile device used to initiate the first connection and by checking the first database for determining if there is a match with the traced-out mobile device. The system operator enables the user to indicate the financial transaction requested using the mobile device via the first connection. The method further includes establishing a second connection between the system operator and the first financial institution for processing the financial transaction. The operator system communicates the SIM chip identifier and the financial request to the first financial institution via the second connection.
Patent NZ-588441-A (NZ)
Title: Method for controlled release of an active agent from oleosomes
Inventor: GUTH JACOB
IPC: A61K8/34
Filed: 2009-04-10
Abstract: A method for the release of an active agent from an oleosome is disclosed, wherein the method comprises the steps of: (i) providing an oleosome formulation comprising an encapsulated active agent and a release control agent selected from glycerin or PEG; and (ii) applying the oleosome formulation to a surface in such a manner that the oleosome structure gradually weakens and substantially disintegrates thereby releasing the active agent from the oleosome formulation.
Patent NZ-591751-A (NZ)
Title: Multi-layered lignocellulosic molded bodies with low formaldehyde emissions
Inventor: WEINKOTZ STEPHAN
IPC: B27N1/00
Filed: 2009-09-09
Abstract: Disclosed herein is a multilayer lignocellulose-containing molding comprising: a middle layer or a plurality of middle layers comprising lignocellulose containing particles obtained by using a binder (a) and a covering layer or a plurality of covering layers comprising lignocellulose containing particles obtained by using a binder (b), the binder (a) being selected from the group consisting of (a1) formaldehyde resins and/or (a2) an organic isocyanate having at least two isocyanate groups; the binder (b) comprising the following components: an aqueous component (I) comprising a polymer A which is composed of the following monomers: a) from 70 to 100% by weight of at least one ethylenically unsaturated mono- and/or dicarboxylic acid (monomer(s) A1) and b) from 0 to 30% by weight of at least one further ethylenically unsaturated monomer which differs from the monomers A1 (monomer(s) A2) and, optionally, a low molecular weight crosslinker having at least two functional groups which are selected from the group consisting of hydroxyl, carboxyl and derivatives thereof, primary, secondary and tertiary amine, epoxy and aldehyde and, optionally, a component (II) as an aqueous dispersion, comprising one or more polymer(s) M which is composed of the following monomers: from 0 to 50% by weight of at least one ethylenically unsaturated monomer which comprises at least one epoxide and/or at least one hydroxyalkyl group (monomer(s) M1) and from 50 to 100% by weight of at least one further ethylenically unsaturated monomer which differs from the monomers M1 (monomer(s) M2) and, optionally, customary additives as component (III), and, where the binder (a) comprises a formaldehyde resin, the binder (b) comprising formaldehyde scavengers.
Patent NZ-591974-A (NZ)
Title: A failsafe electrical lock that when a powerfailure happens can be opened from the inside but not the outside
Inventor: STAFILIDIS EMANUEL
IPC: E05B47/00
Filed: 2009-08-27
Abstract: 591974 An electrical lock 30 for use in securing a door, the electronic lock 30 comprising electronic fail safe mechanism 32 operable on opening means of the inside of the door to a secure premises, and electronic fail secure mechanism 34 operable on opening means 28 on the outside of the door to the secure premises, and an electronic controller responsive to electrical signals and adapted to supply power to the electronic fail safe and fail secure mechanisms. In the event of a loss of power to the electronic lock 30, the opening means of the electronic lock 30 can be used to open the door from the inside but not from the outside of the door. When power is being supplied to the electronic lock 30 the electronic controller supplies power to the electronic fail safe mechanism 32 and at the same time, does not supply power to the electronic fail secure mechanism 34 until the controller receives an electrical signal that causes the electronic controller to cut off power to the fail safe actuator and/or to supply power to the fail secure actuator, thereby allowing the door opening means 28 on the outside of the door to unsecure the lock so as to open the door.
Patent NZ-592183-A (NZ)
Title: A water heater comprising a tank and a heat exchanger, wherein the heat exchanger has a first and second part, the second part being encased in a hollow cylinder which creates an insulative air gap
Inventor: PUSSELL PATRICK
IPC: F24H1/20
Filed: 2009-09-24
Abstract: 592183 Disclosed is a water heater which includes a tank adapted for containing water and a heat exchanger (10) substantially within the tank. The heat exchanger has a first part (12), through which a heat exchanging medium flows, and a second part (14), through which the heat exchanging medium flows. The majority of the length of the exterior of the first part of the heat exchanger is in direct heat exchanging contact with the water in the tank via heat exchanging fins (22) attached thereto. The majority of the length of the exterior of the second part is surrounded by a hollow cylinder (24) which creates an insulative air gap between the majority of the length of the exterior of the second part and the water in the tank. The first and second parts are in fluid communication.
Patent NZ-602174-A (NZ)
Title: Cell programming
Inventor: DOTTORI MIRELLA
IPC: C12N5/0797
Filed: 2011-02-04
Abstract: Disclosed is a method of reprogramming a mature mammalian somatic cell into a reprogrammed multi-potent neural precursor cell, said method comprising the steps of: a) delivering one or more transcription factors, nucleic acid molecules encoding said transcription factors, or small molecules capable of influencing the amount present in said somatic cell to said somatic cell, wherein said one or more transcription factors, nucleic acid molecules encoding said transcription factors, or small molecules capable of influencing the amount present in said somatic cell determine the lineage specificity of said neural precursor cell; and b) culturing said somatic cell under conditions permissive to the culture of said neural precursor cell.
Patent NZ-606097-A (NZ)
Title: Protective foot for a unit load, in particular concrete tower segments
Inventor: ALBRECHTS HARALD
IPC: F03D11/04
Filed: 2011-07-25
Abstract: 606097 The disclosure relates to a protective foot for a unit load, in particular a segment from a length of tower or a concrete tower segment of a wind turbine. Said foot has a unit load comprising a base plate (1) for receiving one end of the unit load (100) and a securing unit that can be detachably secured to the first end of the unit load.
Patent NZ-607911-A (NZ)
Title: Apparatus for removing air contaminants
Inventor: KIM JONG IN
IPC: B01D47/02
Filed: 2011-09-21
Abstract: An apparatus for removing air contaminants, which adsorbs dust and harmful substances contained in the air using an absorbing unit/filter (300) connected to an inlet pipe (200) inserted in a tank (100). There are means inside the tank to keep the filter wet (110, 120, 130), and the filter may further be at least partly immersed in water (900). The inlet pipe (200) or outlet pipe (105) may have means (e.g. a fan) (210) to move air through the apparatus. The filter (300) may be in the form of a fibre web which wraps one end of the inlet pipe (200).
Patent NZ-618746-A (NZ)
Title: Fire suppression valve improvements
Inventor: SCHLATTER HEINZ
IPC: A62C35/02
Filed: 2012-04-27
Abstract: A valve (10) for a fire suppression system in particular a movable valve member (100) for the valve. The fire suppression system comprises a reservoir to contain a fire suppressant material, said reservoir having an outlet, at least one nozzle from which the suppressant is delivered, and a valve governing passage of the suppressant to the nozzles. The valve comprises a movable valve member (100) and first (22a) and second (22b) valve seats cooperating therewith, said valve member being movable from a first position seated with respect to said first valve seat preventing communication between said reservoir and said at least one nozzle, to a second position seated with respect to said second valve seat permitting the flow of said suppressant material from said reservoir to said at least one nozzle and preventing suppressant flow to an actuator operatively associated with said valve to selectively cause movement of said valve member from said first position to said second position.
Patent NZ-620025-A (NZ)
Title: Treatment of type 2 diabetes with fty720
Inventor: MA ZHONGMIN
IPC: A61P3/10
Filed: 2012-08-03
Abstract: Disclosed is the use of the sphingosine-1-phosphate receptor modulator 2-amino-2-(hydroxymethyl)-4-(4-octylphenyl)butyl dihydrogen phosphate (FTY720/Fingolimod/Gilenya) and FTY720-P (Fingolimod-phosphate) for prevention and treatment of type-2 diabetes. The compounds, which are FDA approved drugs for treating multiple sclerosis, are demonstrated to normalize fasting glucose levels.
Patent NZ-628713-A (NZ)
Title: Directional spray actuator
Inventor: GILLESPIE BENJAMIN CYRIL
IPC: B05B15/68
Filed: 2013-03-05
Abstract: A directional spray actuator, for a pressurised (e.g. aerosol) container containing at least one liquid to be dispensed. The container has a valve and valve stem. The spray actuator has a body mountable on the container and a valve actuator is hingedly mounted on the body. The inlet of the valve actuator is connected to the valve stem. A nozzle component (50) is rotatably mounted on the body, and has two product passageways, which have parallel nozzles (67) to dispense the liquid. The inlet portions (61, 65) of the nozzle component are e.g. at right angles, for selective connection to the outlet, of the valve actuator, so that the liquid can be dispensed in respective directions relative to the aerosol container. The nozzle portion is rotated to select the inlet portion in communication with the outlet which directs the nozzles in the selected direction.
Patent NZ-701451-A (NZ)
Title: Intravenous formulations of coenzyme q10 (coq10) and methods of use thereof
Inventor: NARAIN NIVEN RAJIN
IPC: A61P35/00
Filed: 2011-03-11
Abstract: Disclosed is a therapeutic formulation suitable for intravenous administration to a subject comprising: an aqueous solution; a hydrophobic active agent; dimyristoylphosphatidyl choline (DMPC); and an opsonization reducer; wherein the hydrophobic active agent is coenzyme Q10; wherein the hydrophobic active agent is dispersed into colloidal nano-dispersion of particles; and wherein the formulation comprises a coenzyme Q10:dimyristoylphosphatidyl choline weight per volume ratio of 4:2 to 4:3.
Patent NZ-705394-A (NZ)
Title: Antibody-drug conjugate
Inventor: MASUDA TAKESHI
IPC: A61K31/48
Filed: 2013-10-10
Abstract: Provided is an antibody-drug conjugate which can be used as an anti-tumor agent, said conjugate being characterized by being produced by binding an anti-tumor compound represented by formula (1) to an antibody through a linker having a structure represented by the formula: -L1-L2-LP-NH-(CH2)n1-La-Lb-Lc- (wherein the antibody is bound at the terminal of L1, and the anti-tumor compound is bound at the terminal of Lc in which the binding site of the anti-tumor compound is a nitrogen atom in an amino group located at position-1).
Patent NZ-712211-A (NZ)
Title: Thymidine kinase diagnostic assay for gene therapy applications
Inventor: LEVY JOHN
IPC: C12N15/00
Filed: 2014-03-14
Abstract: Nucleic acid sequences encoding improved Herpes Simplex Virus Thymidine Kinases (HSV-TK) are provided, including their use in diagnostic and therapeutic applications. The HSV-TK polynucleotide encodes a mutated form of HSV-TK comprising mutations at amino acid residues 32, 33, and 168, wherein the amino acid residues 32 and 33 are each independently mutated to an amino acid chosen from the group consisting of glycine, serine, glutamic acid, an acidic amino acid and cysteine, and wherein the mutated form of HSV-TK increases cell kill activity relative to a wild-type HSV-TK. Also provided are gene therapeutic systems, including viral and retroviral particles.
Patent NZ-729460-A (NZ)
Title: Methods for treating protozoan infections
Inventor: PAGE STEPHEN
IPC: A61K31/155
Filed: 2015-08-28
Abstract: The invention provides compounds of Formula (I), and their use in methods for treating or preventing a protozoan infection in a subject using a compound of Formula (I). The invention also provides the use of a compound of Formula (I) in the manufacture of a medicament for the treatment of a protozoan infection in a subject. The invention further provides a medical device when used in a method of treating or preventing a protozoan infection in a subject and to a medical device comprising the composition of the invention.
Patent NZ-734504-A (NZ)
Title: Humanized rodents that express heavy chains containing vl domains
Inventor: MACDONALD LYNN
IPC: C07K16/46
Filed: 2013-02-01
Abstract: Disclosed is a non-human animal comprising (a) an insertion of one or more human VL and one or more human JL gene segments upstream of an non-human immunoglobulin light chain constant region, (b) an insertion of one or more human VL and one or more human JL gene segments upstream of an non-human immunoglobulin heavy chain constant region, and (c) a nucleotide sequence that encodes an ADAM6 protein or a functional fragment thereof, wherein the ADAM6 protein is expressed from an ectopic ADAM6 nucleic acid sequence.
Patent NZ-740090-A (NZ)
Title: Stabiliser-free cottage cheese, a thickened dairy liquid suitable for its production, and related methods
Inventor: ANDERSEN CLAUS
IPC: A23C19/076
Filed: 2016-08-24
Abstract: The present invention pertains to a stabiliser-free cottage cheese, a thickened, stabiliser-free dairy liquid which is suitable as dressing for the cottage cheese and to methods of producing both the thickened dairy liquid and the cottage cheese.
Patent NZ-746167-A (NZ)
Title: Beta-caseins and cognitive function
Inventor: CLARKE ANDREW JOHN
IPC: A61K35/20
Filed: 2017-03-29
Abstract: Improving the cognitive function of an animal by providing a composition containing beta-casein, wherein at least 75% by weight of the beta-casein is a beta-casein variant that does not produce BCM-7 on digestion in the gut of the animal.
Patent NZ-748938-A (NZ)
Title: Protective surface coatings for flow cells
Inventor: RAMIREZ SEAN M
IPC: B01L3/00
Filed: 2018-05-02
Abstract: An example of a method includes modifying an exposed surface of a substrate to incorporate a first chemical group; reacting the first chemical group with a first reactive group of a functionalized polymer molecule to form a functionalized polymer coating layer covalently bound to the exposed surface of the substrate; grafting a primer to the functionalized polymer coating layer by reacting the primer with a second reactive group of the functionalized polymer coating layer; and forming a water-soluble protective coating on the primer and the functionalized polymer coating layer. Examples of flow cells incorporating examples of the water-soluble protective coating are also disclosed herein.